Severity
Moderate
FDA Drug recall · Reported February 14, 2018
Marketed Without An Approved NDA/ANDA: Flawless Beauty, LLC is voluntarily recalling all lots of different products sold individually or as part of multi-unit kits in accordance w…
Flawless Beauty LLC recalled Relumins Advanced Glutathione kits, 900 mg vials, 1500 mg vials and 3000 mg vials - a moderate-severity action.
Relumins Advanced Glutathione kits, 900 mg vials, 1500 mg vials and 3000 mg vials was recalled by Flawless Beauty LLC in February 14, 2018. Reason: Marketed Without An Approved NDA/ANDA: Flawless Beauty, LLC is voluntarily recalling all lots of different pr…. Check the official notice for the remedy. Verify recall #D-0324-2018 with the FDA Drug before acting.
The recall
Flawless Beauty LLC issued this moderate-severity FDA Drug recall-Marketed Without An Approved NDA/ANDA: Flawless Beauty, LLC is voluntarily recalling all lots of different pr….
Sourced from official FDA Drug enforcement records. Verify recall #D-0324-2018 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0324-2018) was formally reported on February 14, 2018, with the manufacturer initiating the action on January 19, 2018. It is classified under Moderate severity (Class II), with a current status of Terminated. Flawless Beauty LLC is listed as the recalling firm, operating out of Asbury Park, NJ. Federal records list the affected scope as N/A.
The documented reason for this recall is: Marketed Without An Approved NDA/ANDA: Flawless Beauty, LLC is voluntarily recalling all lots of different products sold individually or as part of multi-unit kits in accordance with Consent Decree of Permanent Injuncti… Distribution data in the federal record shows the product reached: Product was distributed U.S.A. nationwide.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
N/A
Related Recalls
6
5 from same agency
Relumins Advanced Glutathione kits, 900 mg vials, 1500 mg vials and 3000 mg vials
Marketed Without An Approved NDA/ANDA: Flawless Beauty, LLC is voluntarily recalling all lots of different products sold individually or as part of multi-unit kits in accordance with Consent Decree of Permanent Injunction ordered by the United States District Court due to misbranding and unapproved new drugs pursuant to the FD&C Act.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | D-0324-2018 |
| Date reported | February 14, 2018 |
| Date initiated | January 19, 2018 |
| Recalling firm | Flawless Beauty LLC |
| Firm location | Asbury Park, NJ |
| Affected scope | N/A |
| Distribution | Product was distributed U.S.A. nationwide. |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported February 14, 2018. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.